Five Faculty Members Elected to Medical and Biological Engineering Elite
Northwestern inductees among 145 engineers who make up AIMBE’s College of Fellows Class of 2017
Five researchers with Northwestern Engineering ties have been elected to the American Institute for Medical and Biological Engineering’s (AIMBE) College of Fellows.
Mitra J.Z. Hartmann, Joseph R. Moskal, Ferdinando Mussa-Ivaldi, John A. Rogers, and Teresa Woodruff are among 145 engineers who make up the College of Fellows Class of 2017. They will be inducted during AIMBE’s 2017 annual meeting on March 20 in Washington, D.C.
The College of Fellows comprises the top two percent of medical and biological engineers in the country. Current AIMBE Fellows have received some of the nation’s highest awards, including the Presidential Medal of Science and Presidential Medal of Technology and Innovation. Many are also members of the National Academy of Engineering, National Academy of Medicine, and National Academy of Sciences.

A member of Northwestern’s Neuroscience and Robotics Lab, Hartmann studies neurobiology and biomechanics of active sensing behaviors. To study these behaviors, her team develops bio-inspired computational models and hardware to test candidate neurobiological algorithms. Her group is particularly interested in how sensory feedback is used in real time to guide motor activity and how movement enables sensory acquisition and perception.

“I am honored to join such an elite group of engineers,” said Moskal, founding director of Northwestern’s Falk Center for Molecular Therapeutics. "I hope this will help motivate the next generation to continue to develop what we have only begun to understand."
Moskal founded and served as chief scientific officer of Naurex, Inc., a drug discovery company that develops therapies for difficult-to-treat depression and other central nervous system diseases. While at Naurex, his team developed rapastinel, a novel therapy for treatment-resistant major depression, which is now in phase III clinical trials. In 2015, Allergan acquired Naurex for $1.7 billion.
Now, Moskal is the co-founder of Aptinyx, Inc., which targets areas of pain, post-traumatic stress disorder, and traumatic brain injury for therapeutic development. Last year, he was inducted into the National Academy of Inventors and the Chicago Area Entrepreneurship Hall of Fame.

Mussa-Ivaldi is responsible for a number of novel scientific achievements, including the first measurement of multi-joint impedance for the human arm. His discoveries have profoundly influenced strategies for motor rehabilitation following stroke and spinal cord injury, on the design of human-machine systems, and on robot control.

Rogers has received numerous honors and awards for his work, including the Lemelson-MIT Prize, a MacArthur Fellowship, a Smithsonian Award for American Ingenuity in the Physical Sciences, and election into the National Academy of Inventors.

A reproductive endocrinologist, Woodruff leads the Oncofertility Consortium, a national team of oncologists, fertility specialists, social scientists, educators, and policymakers to translate her research to the clinical care of women who will lose their fertility due to cancer treatment. Her many awards include the US Presidential Award for Excellence in Science and Mentoring, the Beacon Award from Frontiers in Reproduction, and the Women in Science Award from the Weitzman Institute. She was also named to Time Magazine’s list of the World’s Most Influential People in 2013.